Percutaneous repair of paravalvular prosthetic regurgitation: patient selection, techniques and outcomes

P Sorajja, R Bae, JA Lesser, WA Pedersen - Heart, 2015 - heart.bmj.com
Paravalvular prosthetic regurgitation is common, affecting 5–10% of surgical prostheses and
40–70% of transcatheter valves. While many patients may suffer no significant morbidity …

[PDF][PDF] Role of modern 3D echocardiography in valvular heart disease

T Shiota - The Korean journal of internal medicine, 2014 - synapse.koreamed.org
Three-dimensional (3D) echocardiography has been conceived as one of the most
promising methods for the diagnosis of valvular heart disease, and recently has become an …

Transcatheter closure of paravalvular defects using a purpose-specific occluder

F Nietlispach, M Johnson, RR Moss… - JACC: Cardiovascular …, 2010 - jacc.org
Objectives: This study sought to describe a method of paravalvular leak closure using a
purpose-specific occlusion device. Background: Transcatheter closure of paravalvular leaks …

Percutaneous mitral and aortic paravalvular leak repair: indications, current application, and future directions

RK Binder, JG Webb - Current cardiology reports, 2013 - Springer
Paravalvular regurgitation (PVR) is a symptomatic or asymptomatic complication after
surgical valve replacement. It may be related to calcification, infection or tissue friability and …

[HTML][HTML] Role of echocardiography for catheter-based management of valvular heart disease

T Shiota - Journal of Cardiology, 2017 - Elsevier
Catheter-based treatment of valvular heart disease, such as transvalvular aortic valve
replacement (TAVR) or mitral clip procedure, has been increasingly accepted as a treatment …

Clinical application of 3-dimensional echocardiography in the USA

T Shiota - Circulation Journal, 2015 - jstage.jst.go.jp
Abstract Three-dimensional (3D) echocardiography is one of the most promising methods
for the diagnosis of cardiac disease. Left and right ventricular size and function are currently …

Percutaneous techniques for mitral valve disease

RJ Cubeddu, IF Palacios - Cardiology clinics, 2010 - cardiology.theclinics.com
To appreciate the mechanistic role of current percutaneous therapies, it is important to
understand the anatomic and functional properties of the mitral valve apparatus. The mitral …

Percutaneous closure of mitral paravalvular leak

MM Jones-Haywood, C Combs, M Pu… - … of cardiothoracic and …, 2013 - jcvaonline.com
PARAVALVULAR LEAKS after valve replacement are not uncommon. The incidence of
postoperative mitral valve paravalvular regurgitation is reported to be between 2% and 17 …

Actualización en técnicas de imagen cardiaca: ecocardiografía, cardiorresonancia y tomografía computarizada

R Aguilar-Torres, JJG de Diego… - Revista Española de …, 2010 - Elsevier
En este artículo se realiza una revisión de las aportaciones más relevantes del
ecocardiograma, la resonancia magnética y la tomografía computarizada a la cardiología …

Looking to the Future of Percutaneous Treatment of Patients with Valvular Heart Disease.

RL Narayan, SK Sharma - Interventional Cardiology Clinics, 2011 - europepmc.org
The development of transcatheter valvular therapeutics has revolutionized interventional
cardiology over the past decade. Nonetheless, despite these prominent advances in …